Xgeva 120 mg/1.7 mL injection Images
Generic Name: denosumab
This medication has been identified as Xgeva 120 mg/1.7 mL injection. It is supplied by Amgen Inc.
Xgeva is used in the treatment of Osteolytic Bone Metastases of Solid Tumors; Giant Cell Tumor of Bone; Hypercalcemia of Malignancy; Osteolytic Bone Lesions of Multiple Myeloma and belongs to the drug class miscellaneous bone resorption inhibitors. Not for use in pregnancy. Xgeva 120 mg/1.7 mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Xgeva
- Generic Name
- denosumab
- Strength
- 120 mg/1.7 mL injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous bone resorption inhibitors
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amgen Inc.
- National Drug Code (NDC)
- 55513-0730
More about Xgeva (denosumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: miscellaneous bone resorption inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
